Revision as of 09:34, 2 April 2024 by Bjoerngerlach (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

The Enhancing Quality in Preclinical Data (EQIPD; originally called European Quality in Preclinical Data) consortium was formed in 2017 with founding members from 29 institutions across 8 different countries with the primary aim to support robustness and reliability of preclinical biomedical research in a collaborative manner.

This project received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777364. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

The consortium worked closely with a large group of associated collaborators, advisors and stakeholders representing research institutions, publishers, funders, learned societies and professional societies, from nearly 110 organizations in Europe and North America.

The EQIPD consortium developed various tools to ensure high data quality without impacting innovation and freedom of research.

We often discuss quality of research data only after a study had been planned and an experiment has finished – resulting in many cases in a waste of time and resources.

EQIPD’s mission is to ensure that all critical quality requirements are considered and implemented during the study design phase and before a study is executed.

To achieve these objectives, EQIPD developed:

  • a Quality System and supports its implementation
  • a program to support research teams from preparing a new project proposal through the execution phase
  • a series of training seminars and workshops for young scientists

Please visit the Guarantors of EQIPD e.V.’s website for additional information